MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.immuni.2021.10.019

Медицинская библиотека · Immunity · 2021

Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability.

Burnett Deborah L, Jackson Katherine J L, Langley David B, Aggrawal Anupria, Stella Alberto Ospina, Johansen Matt D, Balachandran Harikrishnan, Lenthall Helen, Rouet Romain, Walker Gregory, Saunders Bernadette M, Singh Mandeep, Li Hui, Henry Jake Y, Jackson Jennifer, Stewart Alastair G, Witthauer Franka, Spence Matthew A, Hansbro Nicole G, Jackson Colin, Schofield Peter, Milthorpe Claire, Martinello Marianne, Schulz Sebastian R, Roth Edith, Kelleher Anthony, Emery Sean, Britton Warwick J, Rawlinson William D, Karl Rudolfo, Schäfer Simon, Winkler Thomas H, Brink Robert, Bull Rowena A, Hansbro Philip M, Jäck Hans-Martin, Turville Stuart, Christ Daniel, Goodnow Christopher C

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Viral mutations are an emerging concern in reducing SARS-CoV-2 vaccination efficacy. Second-generation vaccines will need to elicit neutralizing antibodies against sites that are evolutionarily conserved across the sarbecovirus subgenus. Here, we immunized mice containing a human antibody repertoire with diverse sarbecovirus receptor-binding domains (RBDs) to identify antibodies targeting conserved sites of vulnerability. Antibodies with broad reactivity against diverse clade B RBDs targeting the conserved class 4 epitope, with recurring IGHV/IGKV pairs, were readily elicited but were non-neutralizing. However, rare class 4 antibodies binding this conserved RBD supersite showed potent neutralization of SARS-CoV-2 and all variants of concern. Structural analysis revealed that the neutralizing ability of cross-reactive antibodies was reserved only for those with an elongated CDRH3 that extends the antiparallel beta-sheet RBD core and orients the antibody light chain to obstruct ACE2-RBD interactions. These results identify a structurally defined pathway for vaccine strategies eliciting escape-resistant SARS-CoV-2 neutralizing antibodies.

Для цитирования: Burnett Deborah L, Jackson Katherine J L, Langley David B, Aggrawal Anupria, Stella Alberto Ospina, Johansen Matt D, Balachandran Harikrishnan, Lenthall Helen, Rouet Romain, Walker Gregory, Saunders Bernadette M, Singh Mandeep, Li Hui, Henry Jake Y, Jackson Jennifer, Stewart Alastair G, Witthauer Franka, Spence Matthew A, Hansbro Nicole G, Jackson Colin, Schofield Peter, Milthorpe Claire, Martinello Marianne, Schulz Sebastian R, Roth Edith, Kelleher Anthony, Emery Sean, Britton Warwick J, Rawlinson William D, Karl Rudolfo, Schäfer Simon, Winkler Thomas H, Brink Robert, Bull Rowena A, Hansbro Philip M, Jäck Hans-Martin, Turville Stuart, Christ Daniel, Goodnow Christopher C. Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability.. Immunity. 2021. DOI: 10.1016/j.immuni.2021.10.019.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.